Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | SGMS2 | Q8NHU3 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | PARP1 | P09874 | 1/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9574717 | 0.98 | HTT (0.73) | HTTALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL29687865 | 0.92 | ALDH1A1 (0.65) | HTTALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL2112521 | 0.91 | HTT (0.63) | HTTALDH1A1TDP1KMT2AMEN1 | |
| Salicylic Acid SCHEMBL6547019 | 0.90 | TDP1 (0.70) | HTTALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL340937 | 0.89 | HTT (0.69) | HTTALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL27898281 | 0.89 | L3MBTL1 (0.66) | HTTALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL6539750 | 0.89 | HTT (0.65) | HTTALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL8415759 | 0.87 | HTT (0.59) | HTTALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL6285513 | 0.87 | ALDH1A1 (0.59) | HTTALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL21022925 | 0.87 | ALDH1A1 (0.59) | HTTALDH1A1TDP1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1315962-A | Novel method for synthesizing Exochelins | KEYSTONE BIOMEDICAL INC (US) | 2001-10-03 | — | — | CN | claimed |
| EP-1105416-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS | Keystone Biomedical, Inc. (US) | 2001-06-13 | — | — | EP | claimed |
| US-6063919-A | ESTERIFICATION OF O-DEPROTECTED DIBENZYL EXOCHELIC ACID WITH BENZYL EPI-COBACTIN, HYDROGENOLYTICALLY REMOVING THE THREE BENZYL GROUPS TO FORM EXOCHELIN 786SM(R) | KEYSTONE BIOMEDICAL, INC. (US) | 2000-05-16 | — | — | US | claimed |
| WO-2000009547-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS | KEYSTONE BIOMEDICAL, INC. (US) | 2000-02-24 | — | — | WO | claimed |
| JP-58096591-A | — | — | None | — | — | JP | disclosed |
| JP-59101393-A | — | — | None | — | — | JP | disclosed |
| US-12552823-B2 | Glucosamine derivatives and pharmaceutical uses thereof | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2026-02-17 | — | — | US | disclosed |
| US-20250353870-A1 | GLUCOSAMINE DERIVATIVES AND PHARMACEUTICAL USES THEREOF | RISEN SUZHOU PHARMA TECH CO LTD (CN) | 2025-11-20 | — | — | US | disclosed |
| EP-4253075-B1 | N,N'-DIARYLUREA DERIVATIVE, MANUFACTURING METHOD THEREOF, AND THERMOSENSITIVE RECORDING MATERIAL USING SAME | SANKO CO LTD (JP) | 2025-10-15 | — | — | EP | disclosed |
| US-12312378-B2 | Glucosamine derivatives for the prevention or treatment of joint disorders | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2025-05-27 | — | — | US | disclosed |
| CN-118302150-A | Method for treating keratin materials or fibres for head gear articles | 花王株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-118302149-A | Method for treating keratin materials or fibres for head gear articles | 花王株式会社 | 2024-07-05 | — | — | CN | disclosed |
| US-4952648-A | Production process of multivalent metal-modified salicylic acid/styrene resin, color-developing agent using the resin and suited for use in pressure-sensitive copying paper sheet and pressure-sensitive copying paper unit employing the agent | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1990-08-28 | — | — | US | disclosed |
| EP-0361040-A2 | Odorless multi-valent metal modified products of salicylic acid copolymers, production processes thereof, and use thereof as color-developing agents for pressure-sensitive copying paper sheets | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-04-04 | — | — | EP | disclosed |
| US-4835133-A | Recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1989-05-30 | — | — | US | disclosed |
| CN-1031235-A | Process for producing polyvalent metal-modified salicylic acid resin, color-developing agent using the resin and suitable for use in pressure-sensitive copying paper, and pressure-sensitive copying paper unit using the color-developing agent | MITSUI TOATSU CHEMICALS (JP) | 1989-02-22 | — | — | CN | disclosed |
| EP-0303443-A2 | Multivalent metal-modified salicylic acid resins, and color-developing agents and copying paper using the resins | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-02-15 | — | — | EP | disclosed |
| US-4719198-A | CONTAINING P-BENZYLOXYBENZOIC ACID BENZYL ESTER; OIL-STABLE IMAGES | JUJO PAPER CO., LTD. (JP) | 1988-01-12 | — | — | US | disclosed |
| JP-S59101393-A | HEAT-SENSITIVE RECORDING SHEET | MITSUBISHI PAPER MILLS LTD | 1984-06-11 | — | — | JP | disclosed |
| JP-S5896591-A | HEAT-SENSITIVE RECORDING SHEET WITH PICTURES HAVING IMPROVED STABILITY | MITSUBISHI PAPER MILLS LTD | 1983-06-08 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353870-A1 | GLUCOSAMINE DERIVATIVES AND PHARMACEUTICAL USES THEREOF | OGT, UGGT1, GLA | HTT 859/4885ALDH1A1 1600/4885TDP1 4136/4885 |
| US-12552823-B2 | Glucosamine derivatives and pharmaceutical uses thereof | SOST, FUT6, SLC5A1 | HTT 1783/4885ALDH1A1 2337/4885TDP1 1848/4885 |
| US-12312378-B2 | Glucosamine derivatives for the prevention or treatment of joint disorders | OGT, UGGT1, FUT6 | HTT 759/4885ALDH1A1 2357/4885TDP1 4380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.